Terms: = Endocrine gland cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Diagnosis
6 results:
1. A comparative study of [
Xi Y; Sun L; Che X; Huang X; Liu H; Wang Q; Meng H; Miao Y; Qu Q; Hai W; Li B; Feng W
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2885-2898. PubMed ID: 37093313
[TBL] [Abstract] [Full Text] [Related]
2. Targeting Glutathione and Cystathionine β-Synthase in Ovarian cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.
Santos I; Ramos C; Mendes C; Sequeira CO; Tomé CS; Fernandes DGH; Mota P; Pires RF; Urso D; Hipólito A; Antunes AMM; Vicente JB; Pereira SA; Bonifácio VDB; Nunes SC; Serpa J
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31635026
[TBL] [Abstract] [Full Text] [Related]
3. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
[TBL] [Abstract] [Full Text] [Related]
4. Human kallikrein 2 (hk2) mRNA in peripheral blood of patients with thyroid cancer: a novel molecular marker?
Roddiger SJ; Renneberg H; Martin T; Tunn UW; Zamboglou N; Kurek R
J Cancer Res Clin Oncol; 2003 Jan; 129(1):29-34. PubMed ID: 12618898
[TBL] [Abstract] [Full Text] [Related]
5. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.
Diamandis EP; Okui A; Mitsui S; Luo LY; Soosaipillai A; Grass L; Nakamura T; Howarth DJ; Yamaguchi N
Cancer Res; 2002 Jan; 62(1):295-300. PubMed ID: 11782391
[TBL] [Abstract] [Full Text] [Related]
6. Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland.
Magklara A; Cheung CC; Asa SL; Diamandis EP
Clin Chim Acta; 2000 Oct; 300(1-2):171-80. PubMed ID: 10958873
[TBL] [Abstract] [Full Text] [Related]
